161 related articles for article (PubMed ID: 16449778)
1. The polymerase chain reaction patents: going, going,... still going.
McDowell D
J R Soc Med; 2006 Feb; 99(2):62-4. PubMed ID: 16449778
[No Abstract] [Full Text] [Related]
2. Three-tiered noninvasive diagnosis in 96% of patients with Duchenne muscular dystrophy (DMD).
Yan J; Feng J; Buzin CH; Scaringe W; Liu Q; Mendell JR; Dunnen JD; Sommer SS
Hum Mutat; 2004 Feb; 23(2):203-204. PubMed ID: 14722924
[No Abstract] [Full Text] [Related]
3. Myriad decision reassures biotechs but diagnostics still murky.
Allison M
Nat Biotechnol; 2011 Sep; 29(9):771-2. PubMed ID: 21904302
[No Abstract] [Full Text] [Related]
4. Patent watch: Diagnostic patents at risk after Federal Circuit decisions.
Noonan K
Nat Rev Drug Discov; 2016 Jun; 15(6):377. PubMed ID: 27199249
[No Abstract] [Full Text] [Related]
5. Diagnostic method patents and harms to follow-on innovation.
Harv Law Rev; 2013 Mar; 126(5):1370-91. PubMed ID: 25330558
[No Abstract] [Full Text] [Related]
6. Should genetic testing go digital?
VanInsberghe M; Heyries KA; Hansen CL
Expert Rev Mol Diagn; 2012 Mar; 12(2):111-4. PubMed ID: 22369369
[No Abstract] [Full Text] [Related]
7. A little light on the Mayo: justifying reversal of the Federal Circuit's Association for Molecular Pathology decision.
Georgek KJ
Seton Hall Law Rev; 2014; 44(1):171-206. PubMed ID: 24654292
[No Abstract] [Full Text] [Related]
8. Fine needle aspiration: past, current practice and recent developments.
Siddig E
Biotech Histochem; 2014 May; 89(4):241-4. PubMed ID: 24359338
[TBL] [Abstract][Full Text] [Related]
9. The future of prenatal molecular diagnostics: impact of the changing patent landscape.
Rachinsky TL
Pharm Pat Anal; 2014 Jan; 3(1):1-3. PubMed ID: 24354971
[No Abstract] [Full Text] [Related]
10. Patently unpatentable: implications of the Myriad court decision on genetic diagnostics.
Cho M
Trends Biotechnol; 2010 Nov; 28(11):548-51. PubMed ID: 20832881
[TBL] [Abstract][Full Text] [Related]
11. The fate and future of patents on human genes and genetic diagnostic methods.
Huys I; Matthijs G; Van Overwalle G
Nat Rev Genet; 2012 May; 13(6):441-8. PubMed ID: 22596320
[TBL] [Abstract][Full Text] [Related]
12. Patents and translational research in genomics.
Kaye J; Hawkins N; Taylor J
Nat Biotechnol; 2007 Jul; 25(7):739-41. PubMed ID: 17621295
[No Abstract] [Full Text] [Related]
13. New rulings on the Cetus patent for taq polymerase.
Leonard DG; Schifreen RS; Sninsky JJ; White TJ
Mol Diagn; 2000 Mar; 5(1):1-3. PubMed ID: 10837081
[No Abstract] [Full Text] [Related]
14. [Current advancement of the PCR-based molecular diagnosis for tuberculous meningitis].
Takahashi T; Tamura M; Takasu T; Kamei S
Rinsho Shinkeigaku; 2013; 53(11):1187-90. PubMed ID: 24291924
[TBL] [Abstract][Full Text] [Related]
15. Cetus retains PCR patents.
Schaefer E
Nature; 1991 Mar; 350(6313):6. PubMed ID: 2002846
[No Abstract] [Full Text] [Related]
16. Revolutionizing the practice of medicine through rapid (< 1h) DNA-based diagnostics.
Bergeron MG
Clin Invest Med; 2008 Oct; 31(5):E265-71. PubMed ID: 18980716
[TBL] [Abstract][Full Text] [Related]
17. Licences sought from PCR users in Britain.
Dickson D
Nature; 1993 Jan; 361(6410):291. PubMed ID: 8426645
[No Abstract] [Full Text] [Related]
18. Cetus battles with Du Pont.
Gershon D
Nature; 1990 Jan; 343(6256):301. PubMed ID: 2300180
[No Abstract] [Full Text] [Related]
19. Shrinking DNA diagnostics to fill the markets of the future.
Hodgson J
Nat Biotechnol; 1998 Aug; 16(8):725-7. PubMed ID: 9702768
[No Abstract] [Full Text] [Related]
20. Litigation escalates for patents on a chip.
Bains W
Nat Biotechnol; 1997 May; 15(5):406. PubMed ID: 9131609
[No Abstract] [Full Text] [Related]
[Next] [New Search]
